Você está em: Start > Publications > Real-world data from the Portuguese Nivolumab Expanded Access Program (EAP) in previously treated Non Small Cell Lung Cancer (NSCLC) [Experiência portuguesa com Nivolumab no Programa de Acesso Precoce (PAP) em doentes com Cancro do Pulmão de Células Não Pequenas (CPCNP) previamente tratado] > View related publications
Copyright 1996-2025 © Faculdade de Direito da Universidade do Porto
I Terms and Conditions
I Acessibility
I Index A-Z
Page created on: 2025-09-26 at 00:15:25 | Privacy Policy | Personal Data Protection Policy | Whistleblowing | Electronic Yellow Book
Page created on: 2025-09-26 at 00:15:25 | Privacy Policy | Personal Data Protection Policy | Whistleblowing | Electronic Yellow Book